Momentum Stocks : Southwest Airlines (NYSE:LUV), Dyax Corp. (NASDAQ:DYAX), Fossil Group (NASDAQ:FOSL), YY Inc. (NASDAQ:YY), Sony Corp (ADR) (NYSE:SNE)

Southwest Airlines Co. (NYSE:LUV) Chief Executive Officer Gary Kelly said, “I don’t see the need to do anything differently.” While Southwest doesn’t fly beyond the Caribbean and Mexico, it could pick up international passengers who fly into several U.S. gateways for flights across the country. Southwest Airlines Co. (NYSE:LUV) belongs to Services sector. Its net profit margin is 6.00% and weekly performance is -4.56%. On … Continue reading Momentum Stocks : Southwest Airlines (NYSE:LUV), Dyax Corp. (NASDAQ:DYAX), Fossil Group (NASDAQ:FOSL), YY Inc. (NASDAQ:YY), Sony Corp (ADR) (NYSE:SNE)

Small Cap Stocks: Universal Display Corporation (NASDAQ:OLED), Heritage-Crystal Clean (NASDAQ:HCCI), IPC The Hospitalist (NASDAQ:IPCM), Dyax Corp. (NASDAQ:DYAX), Lightinthebox Holding (NYSE:LITB)

Goldman, a long-time Universal Display Corporation (NASDAQ:OLED)) bull, has issued another upbeat note: The firm sees a variety of upcoming mobile, TV, and wearables product launches boosting Universal’s growth.Goldman recently argued Samsung’s new Galaxy Tab S (features a 2K OLED display) will act as a positive catalyst; volumes should be much lower than the Galaxy S5 and Note 3′s, but revenue/device higher. Universal Display Corporation … Continue reading Small Cap Stocks: Universal Display Corporation (NASDAQ:OLED), Heritage-Crystal Clean (NASDAQ:HCCI), IPC The Hospitalist (NASDAQ:IPCM), Dyax Corp. (NASDAQ:DYAX), Lightinthebox Holding (NYSE:LITB)

Biotech Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), MannKind Corporation (NASDAQ:MNKD), Questcor Pharmaceuticals Inc (NASDAQ:QCOR), Dyax Corp. (NASDAQ:DYAX), Illumina (NASDAQ:ILMN)

Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) Director Gary E. Frashier unloaded 55,000 shares of the stock on the open market in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $8.00, for a total transaction of $440,000.00. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was -3.07% in last session and finished the day at $7.58. Traded volume was 13.15million shares … Continue reading Biotech Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), MannKind Corporation (NASDAQ:MNKD), Questcor Pharmaceuticals Inc (NASDAQ:QCOR), Dyax Corp. (NASDAQ:DYAX), Illumina (NASDAQ:ILMN)

Gilead Sciences GILD NASDAQ:GILD

Biotech GAiners: BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax Corp. (NASDAQ:DYAX), Novavax, Inc. (NASDAQ:NVAX), Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares closed up nearly 11% on Tuesday after the company reported positive data from its OPuS-1 mid-stage study involving BCX4161 as a treatment for hereditary angioedema, or HAE. This is a rare immune disorder that can cause swelling of the face, breathing airways, and also causes abdominal cramping. According to the preliminary results from the company’s proof-of-concept study, BCX4161 met both … Continue reading Biotech GAiners: BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax Corp. (NASDAQ:DYAX), Novavax, Inc. (NASDAQ:NVAX), Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

Biotech Most Volatile: Celldex Therapeutics (NASDAQ:CLDX), Dyax Corp. (NASDAQ:DYAX), Insmed Incorporated (NASDAQ:INSM), Novavax (NASDAQ:NVAX)

Celldex Therapeutics Inc. (NASDAQ:CLDX) options contracts experienced a new 90-day record for call contracts where a total of 5,803 call contracts were traded in the busy trading session. The contract spread yielded a 0.58 put/call ratio where 1.7 call contracts were traded for each put contract. Celldex Therapeutics, Inc. (NASDAQ:CLDX) stock performance was 0.07% in last session and finished the day at $13.73. Traded volume … Continue reading Biotech Most Volatile: Celldex Therapeutics (NASDAQ:CLDX), Dyax Corp. (NASDAQ:DYAX), Insmed Incorporated (NASDAQ:INSM), Novavax (NASDAQ:NVAX)

FB Nasdaq FB Facebook

Hot BiotecH Stocks: Alnylam Pharmaceuticals (NASDAQ:ALNY), Sangamo Biosciences (NASDAQ:SGMO), Dyax Corp. (NASDAQ:DYAX), Synthetic Biologics Inc (NYSEMKT:SYN)

It was the biggest loser on the Bloomberg Massachusetts Index: Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), down more than 12 percent. The Cambridge company is developing a new class of medicines based on RNA interference, or RNAi. Alnylam believes that RNAi therapeutics are a promising approach to silence disease-causing genes, according to its website. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stock performance was -12.11% in last session and finished … Continue reading Hot BiotecH Stocks: Alnylam Pharmaceuticals (NASDAQ:ALNY), Sangamo Biosciences (NASDAQ:SGMO), Dyax Corp. (NASDAQ:DYAX), Synthetic Biologics Inc (NYSEMKT:SYN)